Xenogesis Company
CRO specialised in preclinical drug metabolism & pharmacokinetics (DMPK), quantitative bioanalysis and expert interpretation.
Technology:
Anti-infective Drugs
Industry:
PharmTech
Headquarters:
Nottingham, Nottingham, United Kingdom
Founded Date:
2011
Employees Number:
11-50
Funding Status:
M&A
Estimated Revenue:
$1M to $10M
Register and Claim Ownership